Literature DB >> 28179135

C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity.

Alexey I Kuzmenkov1, Steve Peigneur2, Anton O Chugunov3, Valentin M Tabakmakher4, Roman G Efremov3, Jan Tytgat2, Eugene V Grishin4, Alexander A Vassilevski5.   

Abstract

We report isolation, sequencing, and electrophysiological characterization of OSK3 (α-KTx 8.8 in Kalium and Uniprot databases), a potassium channel blocker from the scorpion Orthochirus scrobiculosus venom. Using the voltage clamp technique, OSK3 was tested on a wide panel of 11 voltage-gated potassium channels expressed in Xenopus oocytes, and was found to potently inhibit Kv1.2 and Kv1.3 with IC50 values of ~331nM and ~503nM, respectively. OdK1 produced by the scorpion Odontobuthus doriae differs by just two C-terminal residues from OSK3, but shows marked preference to Kv1.2. Based on the charybdotoxin-potassium channel complex crystal structure, a model was built to explain the role of the variable residues in OdK1 and OSK3 selectivity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cysteine-stabilized α/β fold (CSα/β); KTx; Pore blockers; Scorpion toxins; Voltage-gated potassium channels

Mesh:

Substances:

Year:  2017        PMID: 28179135     DOI: 10.1016/j.bbapap.2017.02.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  4 in total

1.  Kalium 2.0, a comprehensive database of polypeptide ligands of potassium channels.

Authors:  Valentin M Tabakmakher; Nikolay A Krylov; Alexey I Kuzmenkov; Roman G Efremov; Alexander A Vassilevski
Journal:  Sci Data       Date:  2019-05-27       Impact factor: 6.444

2.  Molecular Dynamics Simulation Reveals Specific Interaction Sites between Scorpion Toxins and Kv1.2 Channel: Implications for Design of Highly Selective Drugs.

Authors:  Shouli Yuan; Bin Gao; Shunyi Zhu
Journal:  Toxins (Basel)       Date:  2017-11-01       Impact factor: 4.546

3.  Tuning Scorpion Toxin Selectivity: Switching From KV1.1 to KV1.3.

Authors:  Andrei M Gigolaev; Alexey I Kuzmenkov; Steve Peigneur; Valentin M Tabakmakher; Ernesto L Pinheiro-Junior; Anton O Chugunov; Roman G Efremov; Jan Tytgat; Alexander A Vassilevski
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

Review 4.  Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Authors:  Jesús Borrego; Adam Feher; Norbert Jost; Gyorgy Panyi; Zoltan Varga; Ferenc Papp
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.